Jasper Therapeutics(us:JSPR)

    21.57

    +0.19%

    Updated on 2024-12-22

    Open:21.12
    Close:21.57
    High:22.20
    Low:21.00
    Pre Close:21.53
    Volume:212530.00
    Amount:4.59M
    Turnover:1.42%
    Shares:15.00M
    MarketCap:323.58M
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-30841454797096.31%241729
    2024-03-31731302088386.31%322021
    2023-12-315011929567106.86%91217
    2023-09-305291547818.26%71118
    2023-06-30578807320679.49%13721
    2023-03-31499361728385.55%27147
    2022-12-31272024659353.22%3710
    2022-09-30272033707253.54%577
    dateorgNametotalratiochangeShareschangeRatio
    2024-03-31Velan Capital Investment Management Lp14719049.76%35000031.20%
    2024-03-31Soleus Capital Management, L.P.11870967.87%19999820.26%
    2024-03-31Carlyle Group Inc.10661897.07%19000021.68%
    2024-03-31Qiming U.S. Ventures Management, Llc9289646.16%769999.04%
    2024-03-31Avidity Partners Management Lp7600005.04%760000
    2024-03-31Franklin Resources Inc7220744.79%722074
    2024-03-31Vanguard Group Inc6127454.06%20344949.71%
    2024-03-31Samsara Biocapital, Llc5250003.48%525000
    2024-03-31Sphera Funds Management Ltd.5052423.35%-207821-29.14%
    2024-03-31Octagon Capital Advisors Lp5008113.32%5400012.09%

    About

    Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company was founded by Judith Shizuru and Susan Prohaska in March 2018 and is headquartered in Redwood City, CA.
    Address:2200 Bridge Parkway,Suite 102

    Market Movers